Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03732209 · ClinicalTrials.gov registry record · Phase 1
A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes
A Phase 1 study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT03732209 is a Phase 1 study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 59 participants.
The verdict
NCT03732209, a Phase 1 study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
The goals of this project are to assess the efficacy of remotely delivered episodic future thinking for reducing delay discounting and improving management of type 2 diabetes, including glycemic control, weight loss, medication adherence, dietary intake, physical activity, and blood pressure. This will be accomplished by randomly assigning participants (N = 64) to episodic future thinking or control thinking groups, while tracking outcome measures before, during, and after the 4-month intervention, as well at a 6-month follow-up visit. Participants in both groups will also receive access to an information-based weight loss intervention.
Interventions
- BEHAVIORAL Episodic future thinking
- BEHAVIORAL Control Thinking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2021-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03732209
The ClinicalTrials.gov registry entry for NCT03732209 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Episodic future thinking is the first listed.
NCT03732209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03732209 about?
NCT03732209 is a clinical study titled "A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes". The goals of this project are to assess the efficacy of remotely delivered episodic future thinking for reducing delay discounting and improving management of type 2 diabetes, including glycemic control, weight loss, medication adherence, dietary intake, physical activity, and blood pressure. This w...
What is the current status of trial NCT03732209?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2019-03-01. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03732209?
The interventions under investigation include: Episodic future thinking (BEHAVIORAL), Control Thinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03732209?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.